Literature DB >> 16382019

Compartment-specific expression and function of the chemokine IP-10/CXCL10 in a model of renal endothelial microvascular injury.

Ulf Panzer1, Oliver M Steinmetz, Rüdiger R Reinking, Tobias N Meyer, Susanne Fehr, André Schneider, Gunther Zahner, Gunter Wolf, Udo Helmchen, Patrick Schaerli, Rolf A K Stahl, Friedrich Thaiss.   

Abstract

The recruitment of inflammatory cells into renal tissue, mainly T cells and monocytes, is a typical feature of various renal diseases such as glomerulonephritis, thrombotic angiopathies, allograft rejection, and vasculitis. T cells predominantly infiltrate the tubulointerstitium, whereas monocytes are present in the tubulointerstitial and glomerular compartment. Because chemokines play a pivotal role in leukocyte trafficking under inflammatory conditions, this study investigated whether a differential expression of chemokines contributes to the precise coordination of leukocyte subtype trafficking in a rat model of renal microvascular endothelial injury. Renal microvascular endothelial injury was induced in rats by selective renal artery perfusion with an anti-endothelial antibody. Induction of the disease led to severe glomerular and tubulointerstitial endothelial injury with subsequent upregulation of chemokines followed by inflammatory cell recruitment. Among the analyzed chemokine mRNA, IP-10/CXCL10 (119-fold), acting via CXCR3 on activated T cells, and MCP-1/CCL2 (65-fold), acting via CCR2 on monocytes, were by far the most strongly upregulated chemokines. In situ hybridization revealed that IP-10/CXCL10 mRNA was selectively expressed by endothelial cells in the tubulointerstitial area, co-localizing with infiltrating T cells. Despite extensive damage of glomerular vasculature, no IP-10/CXCL10 expression by glomerular endothelial cells was detected. MCP-1/CCL2 mRNA in contrast was detectable in the glomerulus and the tubulointerstitium. Treatment with a neutralizing anti-IP-10/CXCL10 antibody significantly reduced the number of infiltrating tubulointerstitial T cells without affecting monocyte migration and led to an improved renal function. Our study demonstrates a role of IP-10/CXCL10 on T cell recruitment in a rat model of renal endothelial microvascular injury. Furthermore, a differential chemokine expression profile by endothelial cells in different renal compartments was found. These findings are consistent with the hypothesis that functional heterogeneity of endothelial cells from different vascular sites exists and provide an insight into the molecular mechanisms that may mediate compartment-specific T cell and monocyte recruitment in inflammatory renal disease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16382019     DOI: 10.1681/ASN.2005040364

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  31 in total

1.  Ubiquitin C-terminal hydrolase-l1 activity induces polyubiquitin accumulation in podocytes and increases proteinuria in rat membranous nephropathy.

Authors:  Catherine Meyer-Schwesinger; Tobias N Meyer; Henning Sievert; Elion Hoxha; Marlies Sachs; Eva-Maria Klupp; Silvia Münster; Stefan Balabanov; Lucie Carrier; Udo Helmchen; Friedrich Thaiss; Rolf A K Stahl
Journal:  Am J Pathol       Date:  2011-05       Impact factor: 4.307

2.  Neutrophil gelatinase-associated lipocalin is instrumental in the pathogenesis of antibody-mediated nephritis in mice.

Authors:  Rahul D Pawar; Milena Pitashny; Simona Gindea; Arlene Tan Tieng; Benjamin Levine; Beatrice Goilav; Sean R Campbell; Yumin Xia; Xiaoping Qing; David B Thomas; Leal Herlitz; Thorsten Berger; Tak W Mak; Chaim Putterman
Journal:  Arthritis Rheum       Date:  2012-05

3.  Endothelial health and diversity in the kidney.

Authors:  Mark S Segal; Chris Baylis; Richard J Johnson
Journal:  J Am Soc Nephrol       Date:  2006-02       Impact factor: 10.121

4.  CXCL5 drives neutrophil recruitment in TH17-mediated GN.

Authors:  Erik M Disteldorf; Christian F Krebs; Hans-Joachim Paust; Jan-Eric Turner; Geraldine Nouailles; André Tittel; Catherine Meyer-Schwesinger; Gesa Stege; Silke Brix; Joachim Velden; Thorsten Wiech; Udo Helmchen; Oliver M Steinmetz; Anett Peters; Sabrina B Bennstein; Anna Kaffke; Chrystel Llanto; Sergio A Lira; Hans-Willi Mittrücker; Rolf A K Stahl; Christian Kurts; Stefan H E Kaufmann; Ulf Panzer
Journal:  J Am Soc Nephrol       Date:  2014-06-05       Impact factor: 10.121

5.  Distinct Modes of Balancing Glomerular Cell Proteostasis in Mucolipidosis Type II and III Prevent Proteinuria.

Authors:  Wiebke Sachs; Marlies Sachs; Elke Krüger; Stephanie Zielinski; Oliver Kretz; Tobias B Huber; Anke Baranowsky; Lena Marie Westermann; Renata Voltolini Velho; Nataniel Floriano Ludwig; Timur Alexander Yorgan; Giorgia Di Lorenzo; Katrin Kollmann; Thomas Braulke; Ida Vanessa Schwartz; Thorsten Schinke; Tatyana Danyukova; Sandra Pohl; Catherine Meyer-Schwesinger
Journal:  J Am Soc Nephrol       Date:  2020-07-08       Impact factor: 10.121

6.  Urinary C-X-C Motif Chemokine 10 Independently Improves the Noninvasive Diagnosis of Antibody-Mediated Kidney Allograft Rejection.

Authors:  Marion Rabant; Lucile Amrouche; Xavier Lebreton; Florence Aulagnon; Aurélien Benon; Virginia Sauvaget; Raja Bonifay; Lise Morin; Anne Scemla; Marianne Delville; Frank Martinez; Marc Olivier Timsit; Jean-Paul Duong Van Huyen; Christophe Legendre; Fabiola Terzi; Dany Anglicheau
Journal:  J Am Soc Nephrol       Date:  2015-05-06       Impact factor: 10.121

7.  Utility of Urinary Biomarkers in Predicting Loss of Residual Renal Function: The balANZ Trial.

Authors:  Yeoungjee Cho; David W Johnson; David A Vesey; Carmel M Hawley; Margaret Clarke; Nicholas Topley
Journal:  Perit Dial Int       Date:  2014-04-07       Impact factor: 1.756

8.  Chemokine expression in renal ischemia/reperfusion injury is most profound during the reparative phase.

Authors:  Ingrid Stroo; Geurt Stokman; Gwen J D Teske; Anje Raven; Loes M Butter; Sandrine Florquin; Jaklien C Leemans
Journal:  Int Immunol       Date:  2010-04-21       Impact factor: 4.823

9.  Kidney dendritic cell activation is required for progression of renal disease in a mouse model of glomerular injury.

Authors:  Felix Heymann; Catherine Meyer-Schwesinger; Emma E Hamilton-Williams; Linda Hammerich; Ulf Panzer; Sylvia Kaden; Susan E Quaggin; Jürgen Floege; Hermann-Josef Gröne; Christian Kurts
Journal:  J Clin Invest       Date:  2009-04-20       Impact factor: 14.808

10.  CXCL9, but not CXCL10, promotes CXCR3-dependent immune-mediated kidney disease.

Authors:  Julia Menke; Geraldine C Zeller; Eriya Kikawada; Terry K Means; Xiao R Huang; Han Y Lan; Bao Lu; Joshua Farber; Andrew D Luster; Vicki R Kelley
Journal:  J Am Soc Nephrol       Date:  2008-03-12       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.